Cardiovascular medical device startup Filterlex Medical has reported positive data from its CAPTIS full-body embolic protection device in a first-in-human (FIH) study.
The next-generation CAPTIS device is designed to lower the risk of stroke as well as other problems during left-heart procedures. It can be deployed and retrieved easily and intuitively.
With a distinctive, triple-action design, the device deflects, captures and removes embolic particles while providing full-body embolic protection.
